Nov 5 (Reuters) - Iq3corp Ltd (IQ3) : ONCOTEX INC, IN WHICH CO HOLDS 40.5% STAKE, GOT LICENSING FOR A GOLD TECHNOLOGY FOR IMMUNE RESPONSE CANCER THERAPY